Abstract:Genetic mutations are the major pathogenic factor of Autism Spectrum Disorder (ASD). In recent years, more and more ASD risk genes have been revealed, among which there are a group of transcriptional regulators. Considering the similarity of the core clinical phenotypes, it is possible that these different factors may regulate the expression levels of certain key targets. Identification of these targets could facilitate the understanding of the etiology and developing of novel diagnostic and therapeutic methods. Therefore, we performed integrated transcriptome analyses of RNA‐Seq and microarray data in multiple ASD mouse models and identified a number of common downstream genes in various brain regions, many of which are related to the structure and function of the synapse components or drug addiction. We then established protein–protein interaction networks of the overlapped targets and isolated the hub genes by 11 algorithms based on the topological structure of the networks, including Sdc4, Vegfa, and Cp in the Cortex‐Adult subgroup, Gria1 in the Cortex‐Juvenile subgroup, and Kdr, S1pr1, Ubc, Grm2, Grin2b, Nrxn1, Pdyn, Grin3a, Itgam, Grin2a, Gabra2, and Camk4 in the Hippocampus‐Adult subgroup, many of which have been associated with ASD in previous studies. Finally, we cross compared our results with human brain transcriptional data sets and verified several key candidates, which may play important role in the pathology process of ASD, including SDC4, CP, S1PR1, UBC, PDYN, GRIN2A, GABRA2, and CAMK4. In summary, by integrated bioinformatics analysis, we have identified a series of potentially important molecules for future ASD research. Autism Res 2020, 13: 352–368. © 2019 International Society for Autism Research, Wiley Periodicals, Inc.Lay SummaryAbnormal transcriptional regulation accounts for a significant portion of Autism Spectrum Disorder. In this study, we performed transcriptome analyses of mouse models to identify common downstream targets of transcriptional regulators involved in ASD. We identified several recurrent target genes that are close related to the common pathological process of ASD, including SDC4, CP, S1PR1, UBC, PDYN, GRM2, NRXN1, GRIN3A, ITGAM, GRIN2A, GABRA2, and CAMK4. These results provide potentially important targets for understanding the molecular mechanism of ASD.

A scalable, high-throughput neural development platform identifies shared impact of ASD genes on cell fate and differentiation

High-throughput single-cell functional elucidation of neurodevelopmental disease-associated genes reveals convergent mechanisms altering neuronal differentiation

Dynamic convergence of autism disorder risk genes across neurodevelopment

Autism genes converge on microtubule biology and RNA-binding proteins during excitatory neurogenesis

Developmental convergence and divergence in human stem cell models of autism spectrum disorder

Autism genes converge on asynchronous development of shared neuron classes

Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development

Convergent Transcriptomic Evidence Reveals the Dysfunctional Quantitative Mechanism of Synaptic Plasticity Control in ASD

Proximity analysis of native proteomes reveals phenotypic modifiers in a mouse model of autism and related neurodevelopmental conditions

Convergent Coexpression of Autism-Associated Genes Suggests Some Novel Risk Genes May Not Be Detectable in Large-Scale Genetic Studies.

Human brain organoids reveal accelerated development of cortical neuron classes as a shared feature of autism risk genes

Targeted Sequencing Identifies 91 Neurodevelopmental Disorder Risk Genes with Autism and Developmental Disability Biases

Integrated Transcriptome Analyses Revealed Key Target Genes in Mouse Models of Autism

Molecular and network disruptions in neurodevelopment uncovered by single cell transcriptomics analysis of CHD8 heterozygous cerebral organoids

Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment

Unveiling promising drug targets for autism spectrum disorder: insights from genetics, transcriptomics, and proteomics

Genome-wide prediction of dominant and recessive neurodevelopmental disorder risk genes

Targeted sequencing and integrative analysis of 3,195 Chinese patients with neurodevelopmental disorders prioritized 26 novel candidate genes

Targeted Sequencing Identifies Risk Variants in 202 Candidate Genes for Neurodevelopmental Disorders

Genome-wide Transcriptome Profiling Reveals the Functional Impact of Rare De Novo and Recurrent CNVs in Autism Spectrum Disorders.